Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Müller

Showing results (41-50 of 140) with videos related to

Pageof 14
Sort By:
The Journal of Gene Medicine|February 6, 2002
Jet nebulization of PEI/DNA polyplexes: physical stability and in vitro gene delivery efficiencyC Rudolph, R H Müller, J Rosenecker
Journal of Basic Microbiology|December 29, 1998
Etherolytic cleavage of 4-(2,4-dichlorophenoxy)butyric acid and 4-(4-chloro-2-methylphenoxy)butyric acid by species of Rhodococcus and Aureobacterium isolated from an alkaline environmentH Mertingk, R H Müller, W Babel
Advanced Drug Delivery Reviews|April 28, 2004
Solid lipid nanoparticles for parenteral drug deliveryS A Wissing, O Kayser, R H Müller
Die Pharmazie|August 4, 2005
Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN) by means of DSC and 1H NMRE Zimmermann, E B Souto, R H Müller
Advanced Drug Delivery Reviews|December 4, 2002
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparationsR H Müller, M Radtke, S A Wissing
Journal of Microencapsulation|July 21, 2006
Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLCE B Souto, W Mehnert, R H Müller
Journal of Microencapsulation|January 13, 2006
A novel approach based on lipid nanoparticles (SLN) for topical delivery of alpha-lipoic acidE B Souto, R H Müller, S Gohla
Die Pharmazie|February 15, 2018
smartLipids<sup>®</sup> as third solid lipid nanoparticle generation - stabilization of retinol for dermal applicationY Ding, S M Pyo, R H Müller
International Journal of Pharmaceutics|August 15, 2002
Nanostructured lipid matrices for improved microencapsulation of drugsR H Müller, M Radtke, S A Wissing
Drug Development and Industrial Pharmacy|November 18, 2011
Development of industrially feasible concentrated 30% and 40% nanoemulsions for intravenous drug deliveryR H Müller, D Harden, C M Keck
Pageof 14

Showing results (41-50 of 140) with videos related to

Sort By:
Pageof 14
The Journal of Gene Medicine|February 6, 2002
Jet nebulization of PEI/DNA polyplexes: physical stability and in vitro gene delivery efficiencyC Rudolph, R H Müller, J Rosenecker
Journal of Basic Microbiology|December 29, 1998
Etherolytic cleavage of 4-(2,4-dichlorophenoxy)butyric acid and 4-(4-chloro-2-methylphenoxy)butyric acid by species of Rhodococcus and Aureobacterium isolated from an alkaline environmentH Mertingk, R H Müller, W Babel
Advanced Drug Delivery Reviews|April 28, 2004
Solid lipid nanoparticles for parenteral drug deliveryS A Wissing, O Kayser, R H Müller
Die Pharmazie|August 4, 2005
Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN) by means of DSC and 1H NMRE Zimmermann, E B Souto, R H Müller
Advanced Drug Delivery Reviews|December 4, 2002
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparationsR H Müller, M Radtke, S A Wissing
Journal of Microencapsulation|July 21, 2006
Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLCE B Souto, W Mehnert, R H Müller
Journal of Microencapsulation|January 13, 2006
A novel approach based on lipid nanoparticles (SLN) for topical delivery of alpha-lipoic acidE B Souto, R H Müller, S Gohla
Die Pharmazie|February 15, 2018
smartLipids<sup>®</sup> as third solid lipid nanoparticle generation - stabilization of retinol for dermal applicationY Ding, S M Pyo, R H Müller
International Journal of Pharmaceutics|August 15, 2002
Nanostructured lipid matrices for improved microencapsulation of drugsR H Müller, M Radtke, S A Wissing
Drug Development and Industrial Pharmacy|November 18, 2011
Development of industrially feasible concentrated 30% and 40% nanoemulsions for intravenous drug deliveryR H Müller, D Harden, C M Keck
Pageof 14